In the meantime, if the results can be confirmed, it would be useful to detect the GG genotype rs743572 of CYP17A1 in clinical practice to predict BPH or MetS or MetS-BPH. This evidence concerns the gene CYP17A1 and benign prostatic hyperplasia.